MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Visuospatial deficits"

  • 2023 International Congress

    The crucial role of the visual system on the PISA syndrome in Parkinson’s disease

    A. Yoritaka, T. Hayashi, K. Fusegi, S. Nakayama, M. Ando, N. Hattori (Koshigaya, Saitama, Japan)

    Objective: Patients with Parkinson's disease (PD) are significantly disturbed in their daily life when accompanied by the PISA syndrome (PS) of lateral bending. Background: We…
  • 2023 International Congress

    Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

    D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: This pilot explored the feasibility and culture-fairness of a psychophysical visuoperceptual test for Parkinson’s disease (PD) in a multicultural population in East London. Background:…
  • 2023 International Congress

    Pareidolias and color discrimination deficits differently correlate with cognitive dysfunction in prodromal Lewy body disease

    S. Kim, JH. Choi, KA. Woo, JY. Joo, HJ. Chang, B. Jeon, JY. Lee (Seoul, Republic of Korea)

    Objective: To investigate color discrimination ability and complex visual illusions known as pareidolias, and their associating factors in patients with iRBD compared to PD and…
  • 2023 International Congress

    Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances

    K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

    Objective: We identified fluorescence-lifetime ophthalmoscopy changes in Parkinson’s disease (PD) patients experiencing visual disturbances. Background: Fluorescence-lifetime ophthalmoscopy (FLIO), a novel in vivo imaging method generating…
  • 2022 International Congress

    The countless visual features in PD and their impact on quality of life. A standardized diagnostic protocol

    M. Meglio, E. Olivola, E. Palermo, G. Fioretto, D. D'Innocenzo, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: Examine multiple aspects of visual functions in PD patients divided into subgroups by stage of disease to establish: the evidence of visual disorders, their…
  • 2022 International Congress

    Circadian cycle and disease phenotype in Parkinson’s disease, insights by motion sensors and molecular biology.

    M. Marano, A. Casamassa, M. Rossi, A. Magliozzi, Z. Yekutieli, A. Vescovi, J. Rosati, V. Di Lazzaro (Rome, Italy)

    Objective: Our aim is to investigate whether the circadian cycle (CC) is linked to the patient Parkinson's disease (PD) profile on a clinical and molecular…
  • 2022 International Congress

    Visual system abnormalities and visual hallucinations in Parkinson’s disease

    M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to identify clinical and imaging biomarkers of visual system injury associated with the presence of Visual hallucinations (VH) in Parkinson's disease (PD).…
  • 2022 International Congress

    Do clinical neuropsychological tasks capture visuoperceptual deficits in culturally-diverse individuals with Parkinson’s disease and hallucinations?

    S. Adamo, M. Statucka, M. Cohn (Toronto, Canada)

    Objective: To explore whether the Judgement of Line Orientation (JLO), VOSP Silhouettes, and VOSP Object Decision tasks distinguish performance of individuals with Parkinson’s Disease (PD)…
  • 2022 International Congress

    Amygdala-hippocampus damage critically contributes to visual dysfunction in Parkinson disease

    P. Reyero, A. Erramuzpe, A. Murueta-Goyena, A. Jimenez-Marin, M. Acera, S. Teijeira-Portas, B. Tijero, R. Del Pino, T. Fernández-Valle, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, U. Ayala, M. Barrenechea, A. Cabrera-Zubizarreta, J. Cortes, J. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To delineate the structural and functional alterations of the brain associated with visual dysfunction and retinal injury in Parkinson disease (PD) Background: Several electrophysiological,…
  • 2022 International Congress

    The 20-item Noise Pareidolia Task is uniquely sensitive to Visual Hallucinations in Parkinson’s Disease

    T. Turner, F. Rodriguez-Porcel (Charleston, USA)

    Objective: The purpose of this study was to examine clinical utility of the 20-item Noise Pareidolia Task (NPT20) in Parkinson’s disease (PD), as indicated by…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24752 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Fasciculations from a cholinesterase inhibitor
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley